Kayshild is recommended for adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis and ...

GLP-1 receptor agonists show promise beyond obesity but require careful use due to sarcopenia risk and complex effects on mental health.

Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.

Hims & Hers Health, Inc. is in trouble. The telehealth platform's compounded GLP-1 weight loss drugs are under the FDA’s and Novo Nordisk’s pressure, causing massive uncertain ...

GLP‑1 weight‑loss drugs are reshaping food and drink manufacturing, driving demand for portion‑smart meals, high‑protein ...

GLP 1 receptor agonists were associated with higher incident chronic cough in adults with type 2 diabetes, with risk ...

Weight-loss drugs keep gaining traction - is that a blessing or a curse for the packaging industry? We dive deeper into the implications of smaller portion sizes, pharmaceutical safety practices ...

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

LONDON — European markets opened in positive territory on Wednesday as investors take stock of the volatile year during Christmas Eve's shortened trading session. The pan-European Stoxx 600 was almost ...

GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...

Thousands of patients are suing over alleged GLP-1 drug injuries. Drugs include Ozempic, Wegovy and Mounjaro.